Publication | Open Access
Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE
76
Citations
10
References
2019
Year
This study suggests that PRRT with 177Lu-DOTATATE is a safe and effective treatment option for patients with inoperable or malignant PGL and PCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1